Search

Your search keyword '"Vicente-Pascual M"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Vicente-Pascual M" Remove constraint Author: "Vicente-Pascual M"
94 results on '"Vicente-Pascual M"'

Search Results

1. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

8. Etiología de la parálisis del nervio hipogloso. Revisión sistemática.

9. Parálisis idiopática del nervio hipogloso. Descripción de un caso.

23. Hormones, Blood Products, and Therapeutic Enzymes

24. Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling

25. Gene Therapy

26. Industrial Challenges of Recombinant Proteins

27. Addressing the Manufacturing Challenges of Cell-Based Therapies

28. Insights on the Formulation of Recombinant Proteins

29. Therapeutic Antibody Engineering and Selection Strategies

30. The Impact of Pharmacogenomics in Personalized Medicine

31. Bioprinting Technologies in Tissue Engineering

32. Advances in Vaccines

33. Cytokines and Growth Factors

34. Interleukin-6, C-Reactive Protein, and Recurrence After Stroke: A Time-Course Analysis of Individual-Participant Data.

35. Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies.

36. C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype: An Individual Participant Data Meta-Analysis

37. C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis.

38. Risk of New-Diagnosed Atrial Fibrillation After Transient Ischemic Attack.

39. Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project.

40. Basal IL-6 and S100b levels are associated with infarct volume.

41. mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation.

42. Bilateral Optic Neuritis Secondary to Immune Etiology by anti-PD-L1 Antibody.

43. α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice.

44. Giant Cell Arteritis: When an Inspection Is Essential.

45. A Less Frequent Etiology of Limb Shaking Syndrome: A Severe Middle Cerebral Artery Stenosis.

46. Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.

47. The influence of organisational management on door-to-needle times for fibrinolytic treatment.

48. Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA.

49. REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients in Catalonia: REMOTE-CAT PROJECT.

50. Induced neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase, a systematic review.

Catalog

Books, media, physical & digital resources